James Riddle, Advarra’s Vice President of Institutional Services, provides his insights on how his IRB is responding to COVID-19-related requests, the recent rise of virtual and at-home visits, and how the FDA’s most recent guidance offers flexibility to sponsors and sites alike.
Advarra is the largest central IRB for pharmaceutical trials.